386 related articles for article (PubMed ID: 34706979)
1. Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules.
Nedelsky NB; Taylor JP
RNA; 2022 Jan; 28(1):97-113. PubMed ID: 34706979
[TBL] [Abstract][Full Text] [Related]
2. ALS and FTD: Where RNA metabolism meets protein quality control.
Mandrioli J; Mediani L; Alberti S; Carra S
Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
[TBL] [Abstract][Full Text] [Related]
3. Phase to Phase with TDP-43.
Sun Y; Chakrabartty A
Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
[TBL] [Abstract][Full Text] [Related]
4. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
5. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.
Rayner SL; Cheng F; Hogan AL; Grima N; Yang S; Ke YD; Au CG; Morsch M; De Luca A; Davidson JM; Molloy MP; Shi B; Ittner LM; Blair I; Chung RS; Lee A
Hum Mol Genet; 2021 May; 30(11):971-984. PubMed ID: 33729478
[TBL] [Abstract][Full Text] [Related]
6. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
7. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum.
Baradaran-Heravi Y; Van Broeckhoven C; van der Zee J
Neurobiol Dis; 2020 Feb; 134():104639. PubMed ID: 31626953
[TBL] [Abstract][Full Text] [Related]
8. RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration.
Ito D; Hatano M; Suzuki N
Sci Transl Med; 2017 Nov; 9(415):. PubMed ID: 29118263
[TBL] [Abstract][Full Text] [Related]
9. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
10. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
11. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
Mackenzie IR; Nicholson AM; Sarkar M; Messing J; Purice MD; Pottier C; Annu K; Baker M; Perkerson RB; Kurti A; Matchett BJ; Mittag T; Temirov J; Hsiung GR; Krieger C; Murray ME; Kato M; Fryer JD; Petrucelli L; Zinman L; Weintraub S; Mesulam M; Keith J; Zivkovic SA; Hirsch-Reinshagen V; Roos RP; Züchner S; Graff-Radford NR; Petersen RC; Caselli RJ; Wszolek ZK; Finger E; Lippa C; Lacomis D; Stewart H; Dickson DW; Kim HJ; Rogaeva E; Bigio E; Boylan KB; Taylor JP; Rademakers R
Neuron; 2017 Aug; 95(4):808-816.e9. PubMed ID: 28817800
[TBL] [Abstract][Full Text] [Related]
12. Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.
Naskar A; Nayak A; Salaikumaran MR; Vishal SS; Gopal PP
Front Mol Neurosci; 2023; 16():1242925. PubMed ID: 37720552
[TBL] [Abstract][Full Text] [Related]
13. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
[TBL] [Abstract][Full Text] [Related]
14. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
15. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
[TBL] [Abstract][Full Text] [Related]
16. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
Kumar V; Islam A; Hassan MI; Ahmad F
Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
[TBL] [Abstract][Full Text] [Related]
17. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.
Murakami T; Qamar S; Lin JQ; Schierle GS; Rees E; Miyashita A; Costa AR; Dodd RB; Chan FT; Michel CH; Kronenberg-Versteeg D; Li Y; Yang SP; Wakutani Y; Meadows W; Ferry RR; Dong L; Tartaglia GG; Favrin G; Lin WL; Dickson DW; Zhen M; Ron D; Schmitt-Ulms G; Fraser PE; Shneider NA; Holt C; Vendruscolo M; Kaminski CF; St George-Hyslop P
Neuron; 2015 Nov; 88(4):678-90. PubMed ID: 26526393
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological implications of RNP granules in frontotemporal dementia and ALS.
Desai P; Bandopadhyay R
Neurochem Int; 2020 Nov; 140():104819. PubMed ID: 32763254
[TBL] [Abstract][Full Text] [Related]
19. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
